Ivabradine in cardiovascular disease management revisited: a review
C Chen, G Kaur, PK Mehta, D Morrone… - … Drugs and Therapy, 2021 - Springer
Ivabradine is a unique agent that is distinct from beta-blockers and calcium channel blockers
as it reduces heart rate without affecting myocardial contractility or vascular tone. Ivabradine …
as it reduces heart rate without affecting myocardial contractility or vascular tone. Ivabradine …
中医药治疗慢性心力衰竭的药理机制与研究进展
王居平， 杨维伦， 施乐 - 实用临床医药杂志, 2020 - jcmp.yzu.edu.cn
慢性心力衰竭是危害人类健康的严重疾病, 具有较高的发病率与死亡率. 慢性心力衰竭病机复杂,
中医治疗具有独特的优势. 现阶段研究已对慢性心力衰竭有着较为深入的认知, 其中神经体液 …
中医治疗具有独特的优势. 现阶段研究已对慢性心力衰竭有着较为深入的认知, 其中神经体液 …
[HTML][HTML] Ivabradine in congestive heart failure: patient selection and perspectives
Heart failure (HF) is the fourth-most frequent cause of death and remains a challenge for
public health. Therapy goals for HF with reduced ejection fraction (HFrEF) are the …
public health. Therapy goals for HF with reduced ejection fraction (HFrEF) are the …
Polypharmacology in Clinical Applications: Cardiovascular Polypharmacology
Z Wang, B Yang - Polypharmacology: Principles and Methodologies, 2022 - Springer
Cardiovascular disease (CVD) is a class of disorders of the heart and blood vessels and the
leading cause of death worldwide. Yet, treatment of CVDs is the major challenge in …
leading cause of death worldwide. Yet, treatment of CVDs is the major challenge in …
[PDF][PDF] Targeting heart rate variability in heart failure: An expert opinion review on Ivabradine
G Unni, H Baxi - IJCS, 2023 - cardiologyjournals.net
Heart rate variability (HRV) in patients with chronic heart failure (CHF) predicts mortality
outcomes. Assessed in time-domain and frequency-domain measures, HRV can be used to …
outcomes. Assessed in time-domain and frequency-domain measures, HRV can be used to …
Pharmacological mechanism and research progress of traditional Chinese medicine in the treatment of chronic heart failure
W Juping, Y Weilun, SHI Le - Journal of Clinical Medicine in Practice - jcmp.yzu.edu.cn
Chronic heart failure, a severe disease threatening human health, has complex
pathogenesis and higher incidence rate as well as mortality rate. Traditional Chinese …
pathogenesis and higher incidence rate as well as mortality rate. Traditional Chinese …
New Perspectives in the Treatment of Acute and Chronic Heart Failure with Reduced Ejection Fraction
C Stătescu, R Sascău, A Clement… - Journal of Cardiovascular …, 2021 - sciendo.com
Acute and chronic heart failure with reduced ejection fraction (HFrEF) is a major public
health problem, studies showing a 25% survival rate at 5 years after hospitalization. If left …
health problem, studies showing a 25% survival rate at 5 years after hospitalization. If left …